Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 5,231 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $195.78, for a total value of $1,024,125.18. Following the completion of the transaction, the chief executive officer owned 83,291 shares of the company’s stock, valued at $16,306,711.98. This trade represents a 5.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Plexus Stock Performance
Shares of PLXS stock traded up $3.93 during mid-day trading on Friday, reaching $200.50. The stock had a trading volume of 83,708 shares, compared to its average volume of 353,789. Plexus Corp. has a 1-year low of $103.43 and a 1-year high of $211.84. The firm has a market cap of $5.37 billion, a price-to-earnings ratio of 31.21 and a beta of 0.81. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The business’s fifty day moving average is $174.70 and its 200-day moving average is $152.80.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same quarter in the prior year, the firm earned $1.73 earnings per share. Plexus’s revenue for the quarter was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, research analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on PLXS
Hedge Funds Weigh In On Plexus
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Corient Private Wealth LLC boosted its stake in shares of Plexus by 4.5% in the fourth quarter. Corient Private Wealth LLC now owns 1,900 shares of the technology company’s stock worth $279,000 after acquiring an additional 82 shares during the last quarter. Caitlin John LLC acquired a new stake in shares of Plexus in the fourth quarter valued at approximately $408,000. Fuller & Thaler Asset Management Inc. lifted its position in Plexus by 5.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 446,705 shares of the technology company’s stock worth $65,666,000 after buying an additional 24,441 shares in the last quarter. XTX Topco Ltd purchased a new stake in Plexus in the 4th quarter valued at $758,000. Finally, Palisade Capital Management LP purchased a new position in shares of Plexus during the 4th quarter worth $2,003,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Read More
- Five stocks we like better than Plexus
- 3 Signs You May Want to Switch Financial Advisors
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- From Quiet Compounder to 2026 Breakout? BSEM
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
